Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PB9563 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-G-CSF/CSF3 Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for G CSF/CSF3 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: ELISA. Reactive species: Human. G CSF/CSF3 information: Molecular Weight: 22293 MW; Subcellular Localization: Secreted.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Ambroxol alleviates ventilator-induced lung injury by inhibiting c-Jun expression.
Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways.
Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways.
Cao DW, Hou MX, Zhang XR
European review for medical and pharmacological sciences 2019 Jun;23(11):5004-5011
European review for medical and pharmacological sciences 2019 Jun;23(11):5004-5011
Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways.
Li XH, Li CY, Xiang ZG, Hu JJ, Lu JM, Tian RB, Jia W
Cardiovascular drugs and therapy 2012 Dec;26(6):457-65
Cardiovascular drugs and therapy 2012 Dec;26(6):457-65
Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways.
Li XH, Li CY, Lu JM, Tian RB, Wei J
Neuroscience letters 2012 Apr 11;514(1):46-50
Neuroscience letters 2012 Apr 11;514(1):46-50
No comments: Submit comment
No validations: Submit validation data